Video: Men Take No Chances With New Birth Control Gel

---------- Forwarded message ----------
From: Wall Street Daily <wallstreetdaily@wallstreetdaily.com>
Date: Thu, Aug 9, 2012 at 6:27 PM
Subject: Video: Men Take No Chances With New Birth Control Gel

This Man Is a "Timing Freak." On September 21-22, 2011, Steve Reitmeister of Zacks Investment Research harvested gains just before the market crashed 675 points. Then on December 19, he smelled a bounce and the market jumped 338 points. Again, on May 29, 2012, he sold his long positions just before most investors were hit by a 480-point sledgehammer. One jubilant follower calls him a "timing freak." Today, something big is taking shape. What is Steve's next market call? Find out free. Video: Men Take No Chances With New Birth Control Gel By Wall Street Daily Research We see it all the time in television dramas like "Desperate Housewives" or movies like "Knocked Up." Not taking birth control seriously leads to one thing: surprise pregnancies. And while things end up working out great in the world of fiction and comedy, it's certainly no laughing matter when a birth control flub happens in real life. That's where this new experimental treatment comes in. Scientists in California have developed a new birth control gel that's showing promising results. But unlike most forms of contraceptive, this product is made for men. Essentially, the gel consists of a combination of two hormones: testosterone, which inhibits a man's ability to produce sperm; and Nestorone, which boosts testosterone's effects. Researchers tested the gel on 99 men over a six-month period. Here's how Dr. Christina Wang of the study describes the results... "The study, in effect, showed two things. [The] first thing is that the addition of the Nestorone to the testosterone... made the combination much more effective in the suppression of sperm production than the testosterone [alone]. The second thing we showed is that if we used the two combined gels together... 89% of the men had suppressed sperm, coming to very low levels that may be compatible with contraception." Talk about mass-market appeal. Here's what one guy said when asked about the new birth control's potential: "I'm sure men would want the responsibility in their own hands and not someone else's... which I'm sure hasn't gone right for everybody." Indeed, there's no question that something like this will fly off the shelves - and become part of everyday life - once it gets official. Now, since this is being developed in a lab at UCLA, there's no way to invest at this time. But our analysts are constantly tracking opportunities to profit from similar technologies. That is, innovations with the potential to change our lives for good. Just upgrade your subscription to WSD Insider to find out more. The Next Big Thing... There's a little-known investment that could make you incredibly rich in the year ahead. A small group of everyday Americans have already discovered its power - and the results have been staggering. So what exactly is this investment? How can you take advantage of it to potentially make a small fortune? And why exactly has a world-renowned analyst dubbed it "the next big thing?" Click here for all the answers... The Hidden Factor Leading This "Safe" Asset to Collapse There's a new factor boosting bond prices right now that most investors aren't talking about. Video: The Unusual Anomaly Hiding Inside the Energy Market Check out this brief video edition of Wall Street Daily that breaks down the current action in the natural gas market. China's Latest Buying Spree (It's Big) CNOOC's acquisition of Nexen was huge - but it was only the beginning. 1. Friday Charts: Yup! Mutual Fund Managers Are Still Pitiful... 2. Gold's Sending Us a Clear "Buy" Signal 3. Three More Bullish Real Estate Charts 4. This Contrarian Play is About to Become An Even Bigger Bargain 5. Tim Cook's Rotten Apple Would You Buy a $6,000 Smartphone?

If you enjoy reading our no-nonsense, unbiased research at Wall Street Daily, feel free to share it with your family, friends and colleagues. Simply send them this link, so they can sign up for the TRUTH... for free, of course.

Republish Wall Street Daily on your Website or blog for free.
LEARN HOW

Have a question for our editorial team?
CONTACT US

Interested in our team exposing the truth on particular topic?
SEND US AN EMAIL

Twitter

Facebook

LinkedIn

RSS

You are receiving this e-mail as a part of your free subscription to the Wall Street Daily e-letter.
Manage your subscription. Or to cancel by mail or for any other subscription issues, write us at:

Wall Street Daily
Attn: Member Services
105 West Monument Street
Baltimore, MD 21201

© 2012 Wall Street Daily, LLC All Rights Reserved
Wall Street Daily, LLC. · 105 West Monument Street · Baltimore, MD 21201
North America: 1.855.405.3939; Fax: 1 410.223.2650
International: +1.410.226.2068; Fax: +1 410.223.2650
Website: WallStreetDaily.com Email: CustomerService@WallStreetDailyInfo.com

Nothing in this email should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice.

We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Protected by copyright laws of the United States and international treaties. This newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Wall Street Daily, LLC. 105 W. Monument Street, Baltimore MD 21201.

--
Jorge U. Saguinsin

www.cheapcures.blogspot.com

www.nuideashare.blogspot.com

www.twitter.com/nuideashare

www.twitter.com/cheapcures

www.facebook.com/Newideashare

www.facebook.com/cheapcures

"Be the best, do your best, expect the best"